All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the Lymphoma Coalition.
Philippe Armand and Roch Houot share information related to the recently launched COVID-HEME initiative including how hematologists can get involved.
COVID-HEME is a peer-to-peer forum for physicians about the care of patients with hematologic malignancies during the COVID-19 pandemic. The goal of this collaborative platform is to improve and accelerate the knowledge and experience of physicians to optimize the management of patients during the pandemic.
To join COVID-HEME, please ask for an invitation at firstname.lastname@example.org
COVID-HEME forum supports hematologists during COVID-19 pandemic
FDA delays decision on lisocabtagene maraleucel for adult patients with large B-cell lymphoma
The U.S. Food and Drug Administration (FDA) has announced that it will not meet the Prescription Drug User Fee Act (PDUFA) action date of November 16, 2020,...
Update on CLL induction therapy
An interview with Astrid Pavlovsky, Fundaleu CHP, Buenos Aires, AR, on the first-line treatment of chronic lymphocytic leukemia (CLL).
Subscribe to get the best content related to lymphoma & CLL delivered to your inbox